FLT1 and breast carcinoma: Brunel and colleagues [75] used CPMV as a biosensor for the detection of tumor cells expressing vascular endothelial growth factor receptor-1 (VEGFR-1), which is expressed in a variety of cancer cells including breast cancers, gastric cancers, and schwannomas.